Literature DB >> 2310655

Effects of acetylsalicylic acid and paracetamol alone and in combination on prostanoid synthesis in man.

H Bippi1, J C Frölich.   

Abstract

1. The present study was designed to investigate the effects of acetylsalicylic acid and paracetamol given separately and in combination on total body and renal PGE2 synthesis in healthy volunteers. 2. In a randomized four-way cross-over study eleven female volunteers received for two consecutive days 3 g day-1 acetylsalicylic acid or 3 g day-1 paracetamol or a combination of 1.5 g day-1 acetylsalicylic acid and 1.5 g day-1 paracetamol, or 1.5 g day-1 acetylsalicylic acid separated by washout phases of at least 5 days. Urinary excretion of the major urinary metabolite of PGE2 (PGE-MUM), PGE2 and creatinine clearance were measured before and on day 2 of each treatment period. Compliance was tested by measuring metabolites of the two drugs in urine. 3. Paracetamol did not reduce urinary excretion of PGE2 whereas both dosages of acetylsalicylic acid caused a significant reduction. 4. The combination of both drugs did not reduce PGE2 excretion more than acetylsalicylic acid alone. 5. All four drug schedules reduced urinary excretion of PGE-MUM significantly.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2310655      PMCID: PMC1380130          DOI: 10.1111/j.1365-2125.1990.tb03640.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  26 in total

1.  Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man.

Authors:  B Rosenkranz; C Fischer; C O Meese; J C Frölich
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

2.  The analgesic problem in the Federal Republic of Germany: analgesic consumption, frequency of analgesic nephropathy and regional differences.

Authors:  W Pommer; G Glaeske; M Molzahn
Journal:  Clin Nephrol       Date:  1986-12       Impact factor: 0.975

Review 3.  Renal prostaglandins and leukotrienes.

Authors:  L A Walker; J C Frölich
Journal:  Rev Physiol Biochem Pharmacol       Date:  1987       Impact factor: 5.545

4.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

5.  Urinary excretion of 2,3-dinor-thromboxane B2 in man under normal conditions, following drugs and during some pathological conditions.

Authors:  O Vesterqvist; K Gréen
Journal:  Prostaglandins       Date:  1984-04

6.  Effect of aprotinin on the renal response to vasopressin in diabetes insipidus rats.

Authors:  G Fejes-Toth; J C Frölich; A Naray-Fejes-Toth
Journal:  J Physiol       Date:  1983-06       Impact factor: 5.182

Review 7.  Renal effects of antipyretic analgesics.

Authors:  R S Nanra
Journal:  Am J Med       Date:  1983-11-14       Impact factor: 4.965

8.  Analgesic and non-steroidal anti-inflammatory drug-associated acute renal failure: a prospective collaborative study.

Authors:  D Kleinknecht; P Landais; B Goldfarb
Journal:  Clin Nephrol       Date:  1986-06       Impact factor: 0.975

9.  Automated liquid chromatographic method for the determination of paracetamol and six metabolites in human urine.

Authors:  G Ladds; K Wilson; D Burnett
Journal:  J Chromatogr       Date:  1987-03-06

10.  Acute renal failure after analgesic drugs including paracetamol (acetaminophen).

Authors:  S Björck; C T Svalander; M Aurell
Journal:  Nephron       Date:  1988       Impact factor: 2.847

View more
  8 in total

1.  Reduced systemic bicyclo-prostaglandin-E2 and cyclooxygenase-2 gene expression are associated with inefficient erythropoiesis and enhanced uptake of monocytic hemozoin in children with severe malarial anemia.

Authors:  Samuel B Anyona; Prakasha Kempaiah; Evans Raballah; Gregory C Davenport; Tom Were; Stephen N Konah; John M Vulule; James B Hittner; Charity W Gichuki; John M Ong'echa; Douglas J Perkins
Journal:  Am J Hematol       Date:  2012-06-23       Impact factor: 10.047

Review 2.  A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjects.

Authors:  Emma J Turtle; James W Dear; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2013-06       Impact factor: 4.335

3.  Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol.

Authors:  B Bannwarth; P Netter; F Lapicque; P Gillet; P Péré; E Boccard; R J Royer; A Gaucher
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

4.  Nitroparacetamol exhibits anti-inflammatory and anti-nociceptive activity.

Authors:  O A al-Swayeh; L E Futter; R H Clifford; P K Moore
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

5.  Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells.

Authors:  Maria G Sciulli; Francesca Seta; Stefania Tacconelli; Marta L Capone; Emanuela Ricciotti; Giuseppa Pistritto; Paola Patrignani
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

6.  The interaction of paracetamol with frusemide.

Authors:  U Martin; L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

7.  Effects of paracetamol on NOS, COX, and CYP activity and on oxidative stress in healthy male subjects, rat hepatocytes, and recombinant NOS.

Authors:  Arne Trettin; Anke Böhmer; Maria-Theresia Suchy; Irmelin Probst; Ulrich Staerk; Dirk O Stichtenoth; Jürgen C Frölich; Dimitrios Tsikas
Journal:  Oxid Med Cell Longev       Date:  2014-03-31       Impact factor: 6.543

8.  Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial.

Authors:  Frank Ruschitzka; Jeffrey S Borer; Henry Krum; Andreas J Flammer; Neville D Yeomans; Peter Libby; Thomas F Lüscher; Daniel H Solomon; M Elaine Husni; David Y Graham; Deborah A Davey; Lisa M Wisniewski; Venu Menon; Rana Fayyad; Bruce Beckerman; Dinu Iorga; A Michael Lincoff; Steven E Nissen
Journal:  Eur Heart J       Date:  2017-11-21       Impact factor: 29.983

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.